id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-302684-r4ger87o	Whisenant, Jennifer G.	TERAVOLT: Thoracic Cancers International COVID-19 Collaboration	2020-05-16		.txt	text/plain	2009	88	37	Albeit with small numbers (n = 22), a publication from China suggested that lung cancer patients had the second-highest risk of developing severe and critical symptoms, ICU admission, and death behind hematological malignancies (Dai et al., 2020) . The goals of TERAVOLT are (1) to determine in patients with thoracic malignancies who develop COVID-19 the demographic, comorbidities, and anticancer therapies that place these patients most at risk for hospitalization and death; (2) to determine the clinical picture of patients with thoracic malignancies infected by SARS-CoV-2, a diagnosis made more difficult when the presentation of the illness is so similar to the daily symptoms endured by many of our patients; (3) to provide practitioners with real-time data on therapies that may impact survival to and (4) to evaluate long-term impacts on care and the delay in care to patients with both curable and incurable thoracic malignancies.	./cache/cord-302684-r4ger87o.txt	./txt/cord-302684-r4ger87o.txt